SiMoA | GenomeWeb

SiMoA

Using Quanterix's Simoa technology, the group developed assays to detect C. diff toxins with a high degree of sensitivity and specificity.

The team's dilution experiments suggest Simoa could be thousands of times more sensitive than standard ELISAs in detecting anti-dengue antibodies.

A team led by researchers at the University of Gothenberg have published a study using Quanterix's Simoa technology to measure the brain protein tau in the blood of hockey players to assess brain injury due to concussions.

This article has been updated to include ImmunArray's participation in the program.

A research team at the University of Gothenburg in Sweden is using Quanterix's Single Molecule Array, or Simoa, platform to identify blood biomarkers related to brain injury.

Quanterix said this week that response to the launch last week of its research-use-only automated Single Molecule Array, or Simoa, platform has been enthusiastic – particularly among developers of laboratory-developed tests – and that it will ship the first of its systems to cust

Quanterix this week launched a commercial, research-use-only version of its Single Molecule Array, Simoa, platform.

Quanterix and BioMérieux recently announced a partnership giving BioMérieux worldwide exclusive rights to Quanterix's Single Molecule Array, or SiMoA, technology for clinical assay development and industrial applications.

Quanterix is now "shifting from an R&D phase to a commercial phase" as it prepares to launch its Simoa platform next year.

By Adam Bonislawski
Scientists at the Forsyth Institute, Beth Israel Deaconess Medical Center, and biomarker firm Quanterix announced this week a collaboration to evaluate protein biomarkers for tuberculosis.

Pages

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.